Effect of ayurvedic preparation in hypertension

Clinical efficacy of an ayurvedic formulation in the management of vyana-bala-vaishayama w.s.r to essential hypertension

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013257

Enrollment

Registered

2018-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: null- Hypertensive

Interventions

Intervention1: Ayurvedic formulation: A Vati is prepared with jatamansi, arjun, gokshur, mandukparni, sarpagandha and tagar. Dose will be 2 tablets B.D. Each tablet of 250mg. Duration of study-90 day

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients without any complication age between 30 to 60 years. SBP- 140-179mmHg DBP- 90-109mmHg

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Patients of either sex 30 to 60 years old found hypertensive will be selectedTimepoint: Patients of either sex 30 to 60 years old found hypertensive will be selected	—

Secondary

Measure	Time frame
To study the etiopathogenesis of Essential Hypertension on the basis of Ayurvedic parameters. To study the effect of Ayurvedic formulation in the management of Essential Hypertension. To provide the reliable, cost effective Ayurvedic treatment for Essential Hypertension.Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr upasna

Professor and Head

dr.opsingh63@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026